Clinical Study
The Risk of Endoscopic Mucosal Resection in the Setting of Clopidogrel Use
Table 2
Comparison of outcomes in the two groups.
| | | Clopidogrel | No APAC |
| | Total number of EMR | 17 | 922 | | GIB | 0 | 10 | | Risk of GIB | 0% | 1.1% | | Relative risk of GIB | 0 | | IE | 1 | 1 | | Risk of IE | 6.3% | 0.1% | | Relative risk of IE | 63 (CI 4–862). |
|
|
